Dear Sir/Madam, With reference to the captioned subject, please find the attached report on investor complaints for the quarter ended 30th June, 2025. You are requested to take the ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Prism Medico and Pharmacy Ltd has filed a quarterly investor complaints report with BSE under SEBI Listing Regulations. For the quarter ended 30 June 2025, the company reported zero complaints pending at the start, zero received during the quarter, zero disposed of, and zero remaining unresolved at the end. The report was also certified by the company's share registrar, Purva Sharegistry (India) Pvt Ltd. The filing was signed by director Davender Singh on 15 July 2025.
This is a routine regulatory compliance filing with no material impact on shareholders or stock price. Zero investor complaints reflects smooth share registry operations during the quarter.